2. Academic Validation
  3. Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight

Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight

  • Mol Biol Rep. 2022 Oct;49(10):10101-10113. doi: 10.1007/s11033-022-07594-9.
Priyanka Saklani 1,  Heena Khan 1,  Thakur Gurjeet Singh 2,  Saurabh Gupta 1,  Amarjot Kaur Grewal 1
Affiliations

Affiliations

  • 1 Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, 140401, India.
  • 2 Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, 140401, India. [email protected].
PMID: 35657450 DOI: 10.1007/s11033-022-07594-9
Abstract

Introduction: Neurodegenerative disorders are a diverse variety of diseases that can be distinguished from developing degeneration of neurons in the CNS. Several Alkaloids have shown mounting effects in neurodegenerative disorders, and berberine is one of them. Demethyleneberberine is a metabolite of berberine that has better blood-brain barrier crossing capacity. Demethyleneberberine possesses anti-inflammatory, anti-oxidant, and mitochondrial targeting properties. However, neither the pharmacological action nor the molecular mechanism of action of demethyleneberberine on neurodegenerative disorders has been explored yet.

Materials and methods: A systematic literature review of PubMed, Medline, Bentham, Scopus, and EMBASE (Elseveier) databases was carried out with the help of keywords like "Demethyleneberberine; neuroinflammation; oxidative stress; Neuroprotective; Neurodegenerative disorders" till date.

Conclusion: This review focus on the neuroprotective potential of demethyleneberberine in neurodegenerative disorders by attenuating different pathways, i.e., NF-κB, MAPK, and AMPK signalling.

Keywords

Demethyleneberberine; Neurodegenerative disorders; Neuroinflammation; Neuroprotective; Oxidative stress.

Figures
Products